Famotidine Powder, For Suspension
Product Images NDC 59651-701

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 59651-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (40 mg/5 mL (50 mL Bottle))

This is a description of Famotidine oral suspension, a medication used to treat heartburn and stomach ulcers. Each 5 mL of the suspension contains 40 mg of famotidine. Before dispensing, pharmacists must reconstitute the medication by adding 46 mL of purified water. The suspension should be shaken well before each use. The suspension should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from freezing. Unused reconstituted suspension should be discarded after 30 days. The medication is distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Str (Famotidine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.